Things like early menarche, preeclampsia, and endometriosis didn’t reclassify risk in women ages 45-69. The question is: why?

The 2025 physician fee schedule (PFS) announced by the Centers for Medicare and Medicaid Services (CMS) last month is set to ...

Greater weight loss was linked to greater savings, which may be directionally correct but isn’t necessarily the whole story.

The optimal revascularization choice may differ between women and men, but low numbers of women prevent firm conclusions.

The reason for the disparity is unknown but is not believed to be genetic. Female athletes appear to be at the lowest risk.

Guidelines still contain strong recommendations for aspirin’s use, but some are calling for new trials to confirm benefits.

In total, 164 programs offered up 326 positions. Of the 290 candidates who applied, 272 secured one on match day.

Patients lost an average of 20.2% of their weight with tirzepatide over 72 weeks versus 13.7% with semaglutide.

An AHA policy statement takes on the nicotine gummies, pouches, and other products that are rapidly proliferating.

Choosing between Pascal and MitraClip comes down to patient anatomy, with both devices working well in most cases.

While surgery leads to more early bleeds and overall bleeds, PCI patients have more postdischarge events through 5 years.

Lack of transparency in early studies and manufacturer summaries are among the issues uncovered during litigation.